Cleveland Clinic this week announced its picks for the top 10 medical innovations of 2014, placing the newly FDA-approved Argus II "bionic eye" from Second Sight in the #1 spot.
The device is a breakthrough for the U.S., designed to restore meaningful eyesight to patients suffering from retinitis pigmentosa, a condition that leaves patients with either bare light perception or none at all. There is currently no cure for the rare condition, which is diagnosed about 250 times each year.
Hear the story behind Second Sight at the 2013 MassDevice Big 100 West on Dec. 10th
Cleveland Clinic’ Top 10 is intended to highlight "innovations that will have a major impact on improving patient care within the next year. Chosen by a panel of physicians and scientists, the latest list is Cleveland Clinic’s 8th.
Other device-based therapies that made the top 10 include NeuroPace’s anti-epilepsy neuromodulation implant, which won unanimous backing from an FDA advisory panel:
As well as a new anesthesia management system with upgraded microelectronics:
And a computer-assisted sedation system that assists non-anesthesia specialists in administering drugs during colonoscopy and esophagogastroduodenoscopy procedures: